Regarding the anti-tumor effects of tipifarnib, we have reported that tipifarnib also exerts anti-tumor effects through the suppression of Rheb farnesylation, leading to the inhibition of the mTOR pathway other than via suppression of HIF-1α in gastric cancer cells [27]. The gene discussed is MTOR; the disease is gastric cancer.